Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1999-7-23
pubmed:abstractText
Nucleoside analogues such as lamivudine and famciclovir are potent drugs for treatment of chronic hepatitis B virus infection. Breakthrough infections during lamivudine therapy are associated with mutations in the YMDD motif and putative B region of the HBV polymerase. This study investigated whether failure of famciclovir therapy is also associated with presence or emergence of particular mutations in the HBV polymerase.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0168-8278
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
749-54
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10365797-2-Aminopurine, pubmed-meshheading:10365797-Amino Acid Sequence, pubmed-meshheading:10365797-Amino Acid Substitution, pubmed-meshheading:10365797-Antiviral Agents, pubmed-meshheading:10365797-DNA Replication, pubmed-meshheading:10365797-Gene Products, pol, pubmed-meshheading:10365797-Genetic Variation, pubmed-meshheading:10365797-Genotype, pubmed-meshheading:10365797-Hepatitis B, pubmed-meshheading:10365797-Hepatitis B virus, pubmed-meshheading:10365797-Humans, pubmed-meshheading:10365797-Longitudinal Studies, pubmed-meshheading:10365797-Molecular Sequence Data, pubmed-meshheading:10365797-Polymerase Chain Reaction, pubmed-meshheading:10365797-RNA-Directed DNA Polymerase, pubmed-meshheading:10365797-Sequence Alignment, pubmed-meshheading:10365797-Treatment Failure
pubmed:year
1999
pubmed:articleTitle
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.
pubmed:affiliation
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität, Hamburg, Federal Republic of Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't